Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a south indian population

Asian Pacific Journal of Cancer Prevention

Volumn 6, Issue 3, 2005, Pages 309-314

  Vijayalakshmi, K ^a   Vettriselvi, V ^a   Krishnan, M ^a   Shroff, Sunil ^a   Vishwanathan, K N ^a   Jayanth, Vikram R ^a   Paul, Solomon F D ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

GSTM1; GSTP1; Polymorphisms; Prostate cancer

Indexed keywords

GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN;

AGED; ARTICLE; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; RISK FACTOR;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 32944455427     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Acevedo C, Opazo JL, Huidobro C, et al (2003). Positive Correlation between single or combined genotypes of CYP1A1and GSTM1 in relation to prostate cancer in Chilean people. The Prostate, 57, 111-7.
2. Aktas D, Ozen H, Atsu N, et al (2001). Glutathione S-transferase M1 gene polymorphism in bladder cancer patients: a marker for invasive bladder cancer? Cancer Genet Cytogenet, 125, 1-4.
3. Aktas D, Hascicek M, Sozen S, Ozen H, Tuncbilek E (2004). CYP1A1 and GSTM1 polymorphic genotypes in patients with Prostate cancer in a Turkish population. Cancer Genet Cytogenet, 154, 81-5.
4. Ali-Osmam F, Akande O, Antoun G et al (1997). Molecular cloning,characterization and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase pi gene variants. Evidence for different catalytic activity of the encoded proteins. J Biol Chem, 272, 10004-12.
5. Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E (2004). Association of CYP17, GSTP1, and PON1 Polymorphisms with the risk of Prostate cancer. The Prostate, 9999, 1-12.
6. Autrup JL, Thomassen LH, Olsen JH, Wolf H, Autrup H (1999). Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev, 8, 525-32.
7. Baker AM, Oberley LW, Cohen MB (1997). Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate, 32, 229.
8. Buch S, Kotekar A, Kawle D, Bhisey R (2001). Polymorphisms at CYP and GST gene loci. Prevalence in the Indian Population . Eur J Clin Pharmacol, 57, 553-5.
9. Debes JD, Yokomizo A, McDonnell SK, et al (2004). Gluthatione- S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet Cytogenet, 155, 82-6.
10. De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999). Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol, 155, 1985-92.
11. DeWeese TL, Hruszkewycz AM, Marnett LJ (2001). Oxidative stress in chemoprevention trials. Urology, 57, 137-140.
12. Ekmann P (1999). Genetic and environmental factors in prostate cancer genesis: Identifying high-risk cohorts. Eur Urol, 35, 362-9.
13. Fleshner NE, Kucuk O (2001). Antioxidant dietary supplements: rationale and current status as chemopreventive agents for prostate cancer. Urology, 57, 90-4.
14. Giovannucci E, Rimm EB, Colditz G, et al (1993). A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst, 85, 1571-79.
15. Gsur A, Haidinger G, Hinteregger S, et al (2001). Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer, 95, 152-5.
16. Hayes JD, Strange RC (2000). Glutathione-S-transferase polymorphisms and their biological consequence. Pharmacology, 61, 154-66.
17. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution ofthe isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.
18. Jemal A, Murray T, Samuels A, et al (2003). Cancer Statistics. CA Cancer J Clin, 53, 5-26.
19. Jeronimo C, Varzim G, Henrique R et al (2002). I105 V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 11, 445-50.
20. Johansson AS, Stenberg G, Widerstein M, Mannervik B (1998). Structure-activity relationship and thermal stability of human glutathione S-transferase P1-1 governed by the H-site residue 10. Mol Biol, 278, 687-98.
21. Kote-Jarai Z, Easton D, Edwards SM, et al (2001). CRC/BPG UK Familial Prostate Cancer Study Collaborators. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics, 11, 325-30.
22. Kelada SN, Kardia SL, Walker AH, et al (2000). The glutathione S-transferase-_ and _ genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev, 9, 1329-34.
23. Li D, Randerath K (1992). Modulation of DNA modification (Icompound) levels in rat liver and kidney by dietary carbohydrate, protein, fat, vitamin, and mineral content. Mutat Res, 275, 47-56.
24. Mehta CR, Patel NR, Gray R (1983). A network algorithm for performing Fischer's Exact test in rxc contingency tables, J Am Statistical Association, 78, 427-34.
25. Medeiros R, Vasconcelos A, Costa S, et al (2004). Metabolic Susceptibility Genes and Prostate Cancer Risk in a Southern European Population: The Role of Glutathione S Transferases GSTM1, GSTM3, and GSTT1 Genetic Polymorphisms. The Prostate, 58, 414-20.
26. Mitrunen K, Jourenkova N, Kataja V, et al (2001). Glutathione S transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev, 10, 229-36.
27. Murata M, Watanabe M, Yamanaka M, et al (2001). Genetic polymorphisms in cytochrome P450 (CYP) 1A1,CY1A2, CYP2E1, glutathione transferases (GST) M1, GSST1, and susceptibility to prostate cancer in the Japanese population. Cancer Lett, 165, 171-7.
28. Nazar-Stewart V, Motulsky AG, Eaton DL, et al (1993). The glutathione S transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res, 53, 2313-8.
29. Nakazato H, Suzuki K, Matsui H, et al (2003). Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in Japanese population. Anticancer Res, 23, 2897-902.
30. Nelson WG, De Marzo AM, DeWeese TL (2001). The molecular pathogenesis of prostate cancer: implications for prostate cancer prevention. Urology, 57, 39-45.
31. Park JY, Schantz SP, Stern JC, Kaur T, Lazarus P (1999). Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics, 9, 497- 504.
32. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 6, 733-43.
33. Rebbeck TR, Walker AH, Jaffe JM, et al (1999). Glutathione Stransferase-m_ (GSTM1) and _q (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev, 4, 283-87.
34. Steinhoff C, Franke KH, Golka K, et al (2000). Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol, 74,521-6.
35. Sundberg K, Johansson AS, Stenberg G, et al (1998). Differences in the catalytic efficiencies of allelic variants of glutathione Stransferase P1- 1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 19, 433-6.
36. Strange RC, Lear JT, Fryer A (1998). Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact, 111-2, 351-64.
37. Shepard TF, Platz EA, Kantoff PW, et al (2000). No association between the I105V polymorphism of the glutathione Stransferase P1 gene (GSTP1) and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev, 9, 1267- 8.
38. Srivastava D, Mandhani A, Mittal B, Mittal RD (2005). Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to Prostate cancer in Northern India. BJU Int, 95, 170-3.
39. Wadelius M, Autrup JL, Stubbins MJ, et al (1999). Polymorphisms in NAT2, CYP2D2, CYP2C19, GSTP1 and their association with Prostate cancer. Pharmacogenetics, 9, 333-40.
40. Wiencke JK, Kelsey KT, Lamela RA, Toscano W (1990). Human glutathione- S-transferase deficiency: a marker of susceptibility to induce chromosome damage. Cancer Res, 50, 1585-90.
41. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 1821-4.
42. Zimniak P, Nandur B, Pikula S, et al (1994). Naturally occurring human Glutathione S-transferase GSTP1 isoforms with isoleucine and valine in position 105 differ in enzymatic properties. Eur J Biochem, 224, 893-9.